Page last updated: 2024-09-05

phosphatidylcholines and Hemorrhagic Disorders

phosphatidylcholines has been researched along with Hemorrhagic Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gorina, E; Harrison, JA; Luk, A; Nugent, DJ; Powell, JS; Soni, A; Stass, H1
Carter, CJ; Chonn, A; Devine, DV; Krikler, SH; Levitt, D1

Trials

1 trial(s) available for phosphatidylcholines and Hemorrhagic Disorders

ArticleYear
Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Biological Availability; Cholesterol; Cholesterol, LDL; Complement C3a; Complement Hemolytic Activity Assay; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Factor VIII; Half-Life; Hemophilia A; Hemorrhagic Disorders; Humans; Infusions, Intravenous; Liposomes; Male; Metabolic Clearance Rate; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Recombinant Proteins

2008

Other Studies

1 other study(ies) available for phosphatidylcholines and Hemorrhagic Disorders

ArticleYear
Fatal bleeding in a patient with a non-specific PT and APTT inhibitor.
    Clinical and laboratory haematology, 1992, Volume: 14, Issue:1

    Topics: Aged; Aged, 80 and over; Antiphospholipid Syndrome; Autoimmune Diseases; Blood Coagulation Factors; Blood Platelets; Female; Hemorrhagic Disorders; Humans; Immunoglobulin G; Immunoglobulin lambda-Chains; Liposomes; Lupus Coagulation Inhibitor; Paraproteinemias; Partial Thromboplastin Time; Phosphatidylcholines; Prothrombin; Prothrombin Time

1992